We are live on
!
Find out more
BA
Broadview Advisors Portfolio holdings
AUM
$324M
1-Year Est. Return
0.76%
This Fund
S&P 500
This Quarter
Est. Return
+1.84%
1 Year Est. Return
-0.76%
3 Year Est. Return
+65.3%
5 Year Est. Return
+87.94%
10 Year Est. Return
–
AUM
$1.03B
AUM Growth
+$29.3M
(+2.9%)
Cap. Flow
+$17M
Cap. Flow
% of AUM
1.65%
Top 10 Holdings %
Top 10 Hldgs %
24.58%
Holding
106
New
6
Increased
26
Reduced
55
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$9.84M |
| 2 |
GTLS
Chart Industries
GTLS
|
+$8.56M |
| 3 |
Astec Industries
ASTE
|
+$8.37M |
| 4 |
FEIC
FEI COMPANY
FEIC
|
+$7.7M |
| 5 |
PRXL
Parexel International Corp
PRXL
|
+$7.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Myriad Genetics
MYGN
|
+$12.4M |
| 2 |
BEAV
B/E Aerospace Inc
BEAV
|
+$11M |
| 3 |
Royal Caribbean
RCL
|
+$9.93M |
| 4 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$8.2M |
| 5 |
MDAS
MEDASSETS INC COM STK (DE)
MDAS
|
+$4.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.81% |
| 2 | Consumer Discretionary | 17.87% |
| 3 | Healthcare | 15.78% |
| 4 | Technology | 14.64% |
| 5 | Miscellaneous | 7.96% |
Similar funds
HJA
HCM
MBT
HI
SIM
MC
MM
BLA
Broadview Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, Broadview Advisors held 106 positions worth $1.03B, up 2.9% from $999M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Broadview Advisors's Q2 2014 filing shows 6 new, 26 increased, 55 reduced and 11 closed positions. Its largest new stake was Exact Sciences: 714,300 shares worth $12.2M. The largest sale was Myriad Genetics, an estimated $12.4M.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Broadview Advisors's largest Q2 2014 buy was Exact Sciences: 714,300 shares worth $12.2M.
- Broadview Advisors added most to Parexel International Corp in Q2 2014, an estimated $7.32M increase.
- Broadview Advisors's biggest Q2 2014 reduction was ROCKWOOD HLDGS INC, cutting an estimated $8.2M.
- Broadview Advisors fully exited Myriad Genetics in Q2 2014, selling an estimated $12.4M.
- Broadview Advisors's ten largest holdings make up 25% of its $1.03B portfolio in Q2 2014.
- Broadview Advisors opened 6 new positions and closed 11 in Q2 2014.
- Broadview Advisors's portfolio value rose 2.9% quarter-over-quarter to $1.03B.
Based on Broadview Advisors's 13F filing for Q2 2014, filed 15 Aug 2014.